X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/dialectic-therapeutics-receives-fda-clearance-of-ind-application-for-lead-antiapoptotic-protein-targeted-degradation-aptad-candidate-dt2216-301239168.html